Even after Merck & Co.’s Keytruda has climbed to the top of the industry’s sales charts and racked up dozens of FDA-a | A ...

Merck (NYSE:MRK) announced on Thursday that its Phase 3 KEYNOTE-B96 trial for its anti-PD-1 therapy Keytruda reached the ...

Merck's KEYNOTE-B96 trial shows Keytruda with chemotherapy improves survival in platinum-resistant recurrent ovarian cancer ...

Corcept Therapeutics CORT announced that it has submitted a marketing authorization application (MAA) seeking approval for ...

Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...

UK's first talc cancer group claim accuses Johnson & Johnson and Kenvue of failing to warn about asbestos risk — £1 billion ...

The new test, called the risk of ovarian cancer algorithm (Roca), calculates a woman’s individual risk based on factors such ...

FARGO, N.D. (Valley News Live) - A 20-year-old college student from the Fargo-Moorhead area is turning her unexpected cancer ...

British women are suing Johnson & Johnson over claims that its baby powder gave them ovarian cancer. More than 3,000 people ...

German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round ...

Those are my choices. I don’t say everybody should do it that way, but it’s important to have the choice. And I don’t regret ...